Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02912572 |
|---|---|
| Brief Title: | Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer |
| First Submitted : | September 20, 2016 |
| First Submitted that Met QC Criteria : | September 22, 2016 |
| First Posted : | September 23, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 19, 2024 |